Conjunctivitis, Allergic
25
0
1
19
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
4.0%
1 terminated out of 25 trials
95.0%
+8.5% vs benchmark
36%
9 trials in Phase 3/4
53%
10 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (25)
OJO-miR: microRNA Expression in Allergic Conjunctivitis.
Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy
Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
A Study of ADX-102 in Subjects With Allergic Conjunctivitis
Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
Corneal Biomechanical Changes of Allergic Conjunctivitis
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Twin SUBLIVAC® Grasses Clinical Efficacy Study